Edition:
India

Shire PLC (SHPG.OQ)

SHPG.OQ on NASDAQ Stock Exchange Global Select Market

159.30USD
9:36pm IST
Change (% chg)

$-2.45 (-1.51%)
Prev Close
$161.75
Open
$158.96
Day's High
$159.61
Day's Low
$158.50
Volume
209,384
Avg. Vol
512,191
52-wk High
$177.51
52-wk Low
$123.73

Select another date:

Mon, Jun 11 2018

Photo

Takeda shareholder group aims to block $62 billion Shire deal

TOKYO A group of Takeda Pharmaceutical Co Ltd shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday.

Takeda shareholder group aims to block $62 billion Shire deal

TOKYO A group of Takeda Pharmaceutical Co Ltd shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday.

UPDATE 1-Takeda shareholder group aims to block $62 bln Shire deal

* Owns 1 pct of shares, needs one third of shareholders to block

UPDATE 1-Shareholders demand Japan's Takeda assuage fears over Shire deal

* Proposal says Shire deal could damage existing shareholders

CORRECTED-OFFICIAL-Shareholders demand Japan's Takeda assuage fears over Shire deal

TOKYO, May 29 Japanese drugmaker Takeda Pharmaceutical Co Ltd faces demands from disgruntled shareholders to put to a vote its $62-billion acquisition of London-listed Shire and do more to assuage concerns over the record-breaking deal.

UPDATE 2-Takeda sees lower annual profit, generics to erode cancer drug sales

* Takeda looking to strengthen pipeline by acquiring Shire (Adds executive comment, details)

Japan's Takeda clinches $62 billion Shire deal as pharma M&A rolls on

LONDON/TOKYO Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry. | Video

Japan's Takeda clinches $62 billion Shire deal as pharma M&A rolls on

LONDON/TOKYO Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry. | Video

Breakingviews - Takeda swallows big dose of risk to buy Shire

LONDON (Reuters Breakingviews) - Takeda Pharmaceutical is swallowing a big dose of risk to buy Shire. The Japanese drugmaker finally struck a deal to take control of its Irish peer, for $62 billion. It can just about make the math work, but requires big spending cuts and a load of debt.

UPDATE 5-Japan's Takeda clinches $62 bln Shire deal as pharma M&A rolls on

* Deal expected to close in first half of 2019 (Adds ratings agency reaction, further details)

Select another date: